Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Haiyan E. Liu"'
Autor:
Haiyan E. Liu, Meghah Vuppalapaty, Christian R. Hoerner, Colin P. Bergstrom, Michael Chiu, Clementine Lemaire, James Che, Amanpreet Kaur, Adam Dimmick, Sean Liu, Thomas J. Metzner, Menna Araya, Steve Crouse, Markus Sprenger-Haussels, Martin Schlumpberger, John T. Leppert, Siegfried Hauch, Elodie Sollier, Alice C. Fan
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Therapies for metastatic castration-resistant prostate cancer (mCRPC) include targeting the androgen receptor (AR) with androgen receptor inhibitors (ARIs) and prostate-specific membrane antigen (PSMA). Having the ability to detec
Externí odkaz:
https://doaj.org/article/f147876cb7db462d84fa5bc412a8c4d4
Autor:
Haiyan E. Liu, Meghah Vuppalapaty, Charles Wilkerson, Corinne Renier, Michael Chiu, Clementine Lemaire, James Che, Melissa Matsumoto, James Carroll, Steve Crouse, Violet R. Hanft, Stefanie S. Jeffrey, Dino Di Carlo, Edward B. Garon, Jonathan Goldman, Elodie Sollier
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Lung cancer is the leading cause of cancer-related mortality worldwide. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapies, based on the evaluation of EGFR mutations, have shown dramatic clinical benefits. EGFR mutation
Externí odkaz:
https://doaj.org/article/723a9ab238364e0eb7b4e993350af58a
Autor:
Corinne Renier, Edward Pao, James Che, Haiyan E. Liu, Clementine A. Lemaire, Melissa Matsumoto, Melanie Triboulet, Sandy Srivinas, Stefanie S. Jeffrey, Matthew Rettig, Rajan P. Kulkarni, Dino Di Carlo, Elodie Sollier-Christen
Publikováno v:
npj Precision Oncology, Vol 1, Iss 1, Pp 1-11 (2017)
Prostate cancer: a “liquid biopsy” test for circulating tumor cells A microfluidic device can rapidly and efficiently isolate circulating tumor cells from the blood of prostate cancer patients. Elodie Sollier-Christen of Vortex Biosciences, Rajan
Externí odkaz:
https://doaj.org/article/48288e4677484c6389f4e410a25bb8ec
Autor:
Kyra Heirich, Jeffrey A. Norton, Violet R. Hanft, Elodie Sollier-Christen, James Che, Ingeborg Tinhofer, Matthew Wiggin, Mark Lee, Teri A. Longacre, Valentina Vysotskaia, Melanie Triboulet, Andre Marziali, George A. Poultsides, Vishnu C. Ramani, Evelyn Kidess-Sigal, Ulrich Keilholz, Stefanie S. Jeffrey, Brendan C. Visser, Haiyan E. Liu
Publikováno v:
Oncotarget
// Evelyn Kidess-Sigal 1, 2, * , Haiyan E. Liu 3, * , Melanie M. Triboulet 2 , James Che 3 , Vishnu C. Ramani 2 , Brendan C. Visser 2 , George A. Poultsides 2 , Teri A. Longacre 4 , Andre Marziali 5 , Valentina Vysotskaia 6 , Matthew Wiggin 5 , Kyra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89fc8e0d12cde3f028a1f8cd396c2ad
http://europepmc.org/articles/PMC5356741
http://europepmc.org/articles/PMC5356741
Autor:
Elodie Sollier, Azadeh Timnak, Jamin Steffen, Haiyan E. Liu, Corinne Renier, Clementine A. Lemaire
Publikováno v:
Clinical Cancer Research. 26:B31-B31
Introduction: Several circulating tumor cell (CTC) technologies have been developed amidst growing interests in the “liquid biopsy” field. The fully automated VTX-1 platform is developed to gently isolate intact CTCs from whole blood with high re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::958ebf39fd0234997baa917f3e6307f3
https://doi.org/10.1158/1557-3265.liqbiop20-b31
https://doi.org/10.1158/1557-3265.liqbiop20-b31
Autor:
Evelyn Kidess-Sigal, James Che, Elodie Sollier-Christen, Vida Shokoohi, Amin Zia, John A. Coller, Corinne Renier, Violet R. Hanft, Melanie Triboulet, Stefanie S. Jeffrey, Vanita Natu, Haiyan E. Liu, Natalie H. Chan, Meghah Vuppalapaty
Publikováno v:
NPJ Genomic Medicine
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-13 (2017)
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-13 (2017)
Genomic characterization of circulating tumor cells (CTCs) may prove useful as a surrogate for conventional tissue biopsies. This is particularly important as studies have shown different mutational profiles between CTCs and ctDNA in some tumor subty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::325d36378ca9358420d890cf72f79709
https://doi.org/10.1038/s41525-017-0034-3
https://doi.org/10.1038/s41525-017-0034-3
Autor:
Sandy Srivinas, Haiyan E. Liu, Rajan P. Kulkarni, James Che, Elodie Sollier-Christen, Stefanie S. Jeffrey, Matthew B. Rettig, Edward Pao, Melanie Triboulet, Clementine A. Lemaire, Melissa Matsumoto, Corinne Renier, Dino Di Carlo
Publikováno v:
NPJ precision oncology, vol 1, iss 1
npj Precision Oncology, Vol 1, Iss 1, Pp 1-11 (2017)
NPJ Precision Oncology
npj Precision Oncology, Vol 1, Iss 1, Pp 1-11 (2017)
NPJ Precision Oncology
There has been increased interest in utilizing non-invasive “liquid biopsies” to identify biomarkers for cancer prognosis and monitoring, and to isolate genetic material that can predict response to targeted therapies. Circulating tumor cells (CT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::359fde585c812960ea53d100fccb7617
https://escholarship.org/uc/item/5mp3m7v0
https://escholarship.org/uc/item/5mp3m7v0
Autor:
Nasim A Barzanian, Meghah Vuppalapaty, Haiyan E. Liu, Steve C. Crouse, James M. Carroll, Elodie Sollier-Christen, James Che, Melissa Matsumoto, Jonathan W. Goldman, Edward B. Garon, Charles Wilkerson, Michael Chiu
Publikováno v:
Cancer Research. 78:1598-1598
Background Lung cancer is the leading cause of cancer-related mortality worldwide and 85% cases are NSCLC. Epidermal growth factor receptor (EGFR) mutations occur in 10-30% of NSCLC patients1. EGFR tyrosine kinase inhibitor (TKI) therapies, based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e344ef11f8535327920408cc27d68f5
https://doi.org/10.1158/1538-7445.am2018-1598
https://doi.org/10.1158/1538-7445.am2018-1598
Autor:
Steve C. Crouse, Charles Wilkerson, Clementine A. Lemaire, Meghah Vuppalapaty, Elodie Sollier-Christen, Haiyan E. Liu, Jonathan W. Goldman
Publikováno v:
Cancer Research. 77:1715-1715
Background: Lung cancer is the leading cause of cancer-related mortality worldwide. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapies, based on the evaluation of EGFR mutation, have shown dramatic clinical benefits. EG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eda94966bbaa61eda27b63da3994ae87
https://doi.org/10.1158/1538-7445.am2017-1715
https://doi.org/10.1158/1538-7445.am2017-1715
Autor:
Evelyn Kidess-Sigal, Vida Shokoohi, Violet R. Hanft, Haiyan E. Liu, James Che, Natalie Chan, Elodie Sollier-Christen, Meghah Vuppalapaty, Stefanie S. Jeffrey, Amin Zia, Corinne Renier, Melanie Triboulet, Vanita Natu, John A. Coller
Publikováno v:
Cancer Research. 77:1724-1724
Background: Genomic characterization of circulating tumor cells (CTCs) provides insights into cancer genetic changes, and might be utilized for cancer prognosis, diagnosis, as well as monitoring of therapeutic efficacy. Targeted Panel Next Generation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::184640da0233614351508074b7e02a02
https://doi.org/10.1158/1538-7445.am2017-1724
https://doi.org/10.1158/1538-7445.am2017-1724